| Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ... The Lancet Neurology 17 (2), 162-173, 2018 | 7987 | 2018 |
| Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS C Walton, R King, L Rechtman, W Kaye, E Leray, RA Marrie, N Robertson, ... Multiple Sclerosis Journal 26 (14), 1816-1821, 2020 | 2282 | 2020 |
| Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci PL De Jager, X Jia, J Wang, PIW De Bakker, L Ottoboni, NT Aggarwal, ... Nature genetics 41 (7), 776-782, 2009 | 1026 | 2009 |
| Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis RE Boeschoten, AMJ Braamse, ATF Beekman, P Cuijpers, P Van Oppen, ... Journal of the neurological sciences 372, 331-341, 2017 | 767 | 2017 |
| Exercise therapy for multiple sclerosis MB Rietberg, D Brooks, BMJ Uitdehaag, G Kwakkel Cochrane database of systematic reviews, 2005 | 756 | 2005 |
| Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease … DD Mikol, F Barkhof, P Chang, PK Coyle, DR Jeffery, SR Schwid, ... The Lancet Neurology 7 (10), 903-914, 2008 | 639 | 2008 |
| Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. I Huitinga, N Van Rooijen, CJ De Groot, BM Uitdehaag, CD Dijkstra The Journal of experimental medicine 172 (4), 1025-1033, 1990 | 609 | 1990 |
| Intracortical Lesions in Multiple Sclerosis: Improved Detection with 3D Double Inversion-Recovery MR Imaging1 JJG Geurts, PJW Pouwels, BMJ Uitdehaag, CH Polman, F Barkhof, ... Radiology 236 (1), 254-260, 2005 | 602 | 2005 |
| Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis SE Baranzini, J Wang, RA Gibson, N Galwey, Y Naegelin, F Barkhof, ... Human molecular genetics 18 (4), 767-778, 2009 | 588 | 2009 |
| Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial F Lublin, DH Miller, MS Freedman, BAC Cree, JS Wolinsky, H Weiner, ... The Lancet 387 (10023), 1075-1084, 2016 | 506 | 2016 |
| Pathway and network-based analysis of genome-wide association studies in multiple sclerosis SE Baranzini, NW Galwey, J Wang, P Khankhanian, R Lindberg, ... Human molecular genetics 18 (11), 2078-2090, 2009 | 481 | 2009 |
| Multiple sclerosis: current knowledge and future outlook CP Kamm, BM Uitdehaag, CH Polman European neurology 72 (3-4), 132-141, 2014 | 446 | 2014 |
| Brain atrophy and lesion load predict long term disability in multiple sclerosis V Popescu, F Agosta, HE Hulst, IC Sluimer, DL Knol, MP Sormani, ... Journal of Neurology, Neurosurgery & Psychiatry 84 (10), 1082-1091, 2013 | 408 | 2013 |
| Surgical treatment options for carpal tunnel syndrome RJPM Scholten, AM van der Molen, BMJ Uitdehaag, LM Bouter, ... Cochrane Database of Systematic Reviews, 2007 | 386 | 2007 |
| Progression of regional grey matter atrophy in multiple sclerosis A Eshaghi, RV Marinescu, AL Young, NC Firth, F Prados, ... Brain 141 (6), 1665-1677, 2018 | 385 | 2018 |
| Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS L Kappos, A Traboulsee, C Constantinescu, JP Eralinna, F Forrestal, ... Neurology 67 (6), 944-953, 2006 | 379 | 2006 |
| Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI JJG Geurts, SD Roosendaal, M Calabrese, O Ciccarelli, F Agosta, ... Neurology 76 (5), 418-424, 2011 | 349 | 2011 |
| Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial R Lieverse, EJW Van Someren, MMA Nielen, BMJ Uitdehaag, JH Smit, ... Archives of general psychiatry 68 (1), 61-70, 2011 | 343 | 2011 |
| Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant MD Steenwijk, JJG Geurts, M Daams, BM Tijms, AM Wink, LJ Balk, ... Brain 139 (1), 115-126, 2016 | 331 | 2016 |
| Safety, tolerability, and efficacy of orally administered cannabinoids in MS J Killestein, ELJ Hoogervorst, M Reif, NF Kalkers, AC Van Loenen, ... Neurology 58 (9), 1404-1407, 2002 | 327 | 2002 |
